Currency Sorters
The research report includes specific segments by region (country), by manufacturers, by Type and ... Read More
Global Opioid Induced Constipation (OIC) Drugs Market Research Report 2024
1 Opioid Induced Constipation (OIC) Drugs Market Overview
1.1 Product Overview and Scope of Opioid Induced Constipation (OIC) Drugs
1.2 Opioid Induced Constipation (OIC) Drugs Segment by Type
1.2.1 Global Opioid Induced Constipation (OIC) Drugs Sales Growth Rate Comparison by Type (2022-2028)
1.2.2 Lubiprostone
1.2.3 Methyl Naltrexone Bromide
1.2.4 Naldemedine
1.2.5 Alvimopan
1.2.6 Others
1.3 Opioid Induced Constipation (OIC) Drugs Segment by Application
1.3.1 Global Opioid Induced Constipation (OIC) Drugs Sales Comparison by Application: (2022-2028)
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Global Opioid Induced Constipation (OIC) Drugs Market Size Estimates and Forecasts
1.4.1 Global Opioid Induced Constipation (OIC) Drugs Revenue 2017-2028
1.4.2 Global Opioid Induced Constipation (OIC) Drugs Sales 2017-2028
1.4.3 Opioid Induced Constipation (OIC) Drugs Market Size by Region: 2017 Versus 2021 Versus 2028
2 Opioid Induced Constipation (OIC) Drugs Market Competition by Manufacturers
2.1 Global Opioid Induced Constipation (OIC) Drugs Sales Market Share by Manufacturers (2017-2022)
2.2 Global Opioid Induced Constipation (OIC) Drugs Revenue Market Share by Manufacturers (2017-2022)
2.3 Global Opioid Induced Constipation (OIC) Drugs Average Price by Manufacturers (2017-2022)
2.4 Manufacturers Opioid Induced Constipation (OIC) Drugs Manufacturing Sites, Area Served, Product Type
2.5 Opioid Induced Constipation (OIC) Drugs Market Competitive Situation and Trends
2.5.1 Opioid Induced Constipation (OIC) Drugs Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Opioid Induced Constipation (OIC) Drugs Players Market Share by Revenue
2.5.3 Global Opioid Induced Constipation (OIC) Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Opioid Induced Constipation (OIC) Drugs Retrospective Market Scenario by Region
3.1 Global Opioid Induced Constipation (OIC) Drugs Retrospective Market Scenario in Sales by Region: 2017-2022
3.2 Global Opioid Induced Constipation (OIC) Drugs Retrospective Market Scenario in Revenue by Region: 2017-2022
3.3 North America Opioid Induced Constipation (OIC) Drugs Market Facts & Figures by Country
3.3.1 North America Opioid Induced Constipation (OIC) Drugs Sales by Country
3.3.2 North America Opioid Induced Constipation (OIC) Drugs Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Opioid Induced Constipation (OIC) Drugs Market Facts & Figures by Country
3.4.1 Europe Opioid Induced Constipation (OIC) Drugs Sales by Country
3.4.2 Europe Opioid Induced Constipation (OIC) Drugs Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Opioid Induced Constipation (OIC) Drugs Market Facts & Figures by Region
3.5.1 Asia Pacific Opioid Induced Constipation (OIC) Drugs Sales by Region
3.5.2 Asia Pacific Opioid Induced Constipation (OIC) Drugs Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Opioid Induced Constipation (OIC) Drugs Market Facts & Figures by Country
3.6.1 Latin America Opioid Induced Constipation (OIC) Drugs Sales by Country
3.6.2 Latin America Opioid Induced Constipation (OIC) Drugs Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Opioid Induced Constipation (OIC) Drugs Market Facts & Figures by Country
3.7.1 Middle East and Africa Opioid Induced Constipation (OIC) Drugs Sales by Country
3.7.2 Middle East and Africa Opioid Induced Constipation (OIC) Drugs Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Opioid Induced Constipation (OIC) Drugs Historic Market Analysis by Type
4.1 Global Opioid Induced Constipation (OIC) Drugs Sales Market Share by Type (2017-2022)
4.2 Global Opioid Induced Constipation (OIC) Drugs Revenue Market Share by Type (2017-2022)
4.3 Global Opioid Induced Constipation (OIC) Drugs Price by Type (2017-2022)
5 Global Opioid Induced Constipation (OIC) Drugs Historic Market Analysis by Application
5.1 Global Opioid Induced Constipation (OIC) Drugs Sales Market Share by Application (2017-2022)
5.2 Global Opioid Induced Constipation (OIC) Drugs Revenue Market Share by Application (2017-2022)
5.3 Global Opioid Induced Constipation (OIC) Drugs Price by Application (2017-2022)
6 Key Companies Profiled
6.1 Ironwood Pharmaceuticals Inc
6.1.1 Ironwood Pharmaceuticals Inc Corporation Information
6.1.2 Ironwood Pharmaceuticals Inc Description and Business Overview
6.1.3 Ironwood Pharmaceuticals Inc Opioid Induced Constipation (OIC) Drugs Sales, Revenue and Gross Margin (2017-2022)
6.1.4 Ironwood Pharmaceuticals Inc Opioid Induced Constipation (OIC) Drugs Product Portfolio
6.1.5 Ironwood Pharmaceuticals Inc Recent Developments/Updates
6.2 Daiichi Sankyo Co Ltd
6.2.1 Daiichi Sankyo Co Ltd Corporation Information
6.2.2 Daiichi Sankyo Co Ltd Description and Business Overview
6.2.3 Daiichi Sankyo Co Ltd Opioid Induced Constipation (OIC) Drugs Sales, Revenue and Gross Margin (2017-2022)
6.2.4 Daiichi Sankyo Co Ltd Opioid Induced Constipation (OIC) Drugs Product Portfolio
6.2.5 Daiichi Sankyo Co Ltd Recent Developments/Updates
6.3 Pfizer
6.3.1 Pfizer Corporation Information
6.3.2 Pfizer Description and Business Overview
6.3.3 Pfizer Opioid Induced Constipation (OIC) Drugs Sales, Revenue and Gross Margin (2017-2022)
6.3.4 Pfizer Opioid Induced Constipation (OIC) Drugs Product Portfolio
6.3.5 Pfizer Recent Developments/Updates
6.4 Progenics Pharmaceuticals Inc
6.4.1 Progenics Pharmaceuticals Inc Corporation Information
6.4.2 Progenics Pharmaceuticals Inc Description and Business Overview
6.4.3 Progenics Pharmaceuticals Inc Opioid Induced Constipation (OIC) Drugs Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Progenics Pharmaceuticals Inc Opioid Induced Constipation (OIC) Drugs Product Portfolio
6.4.5 Progenics Pharmaceuticals Inc Recent Developments/Updates
6.5 Shionogi & Co., Ltd
6.5.1 Shionogi & Co., Ltd Corporation Information
6.5.2 Shionogi & Co., Ltd Description and Business Overview
6.5.3 Shionogi & Co., Ltd Opioid Induced Constipation (OIC) Drugs Sales, Revenue and Gross Margin (2017-2022)
6.5.4 Shionogi & Co., Ltd Opioid Induced Constipation (OIC) Drugs Product Portfolio
6.5.5 Shionogi & Co., Ltd Recent Developments/Updates
6.6 Allergan Plc
6.6.1 Allergan Plc Corporation Information
6.6.2 Allergan Plc Description and Business Overview
6.6.3 Allergan Plc Opioid Induced Constipation (OIC) Drugs Sales, Revenue and Gross Margin (2017-2022)
6.6.4 Allergan Plc Opioid Induced Constipation (OIC) Drugs Product Portfolio
6.6.5 Allergan Plc Recent Developments/Updates
6.7 Nektar Therapeutics
6.6.1 Nektar Therapeutics Corporation Information
6.6.2 Nektar Therapeutics Description and Business Overview
6.6.3 Nektar Therapeutics Opioid Induced Constipation (OIC) Drugs Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Nektar Therapeutics Opioid Induced Constipation (OIC) Drugs Product Portfolio
6.7.5 Nektar Therapeutics Recent Developments/Updates
6.8 Purdue Pharma
6.8.1 Purdue Pharma Corporation Information
6.8.2 Purdue Pharma Description and Business Overview
6.8.3 Purdue Pharma Opioid Induced Constipation (OIC) Drugs Sales, Revenue and Gross Margin (2017-2022)
6.8.4 Purdue Pharma Opioid Induced Constipation (OIC) Drugs Product Portfolio
6.8.5 Purdue Pharma Recent Developments/Updates
6.9 S.L.A. Pharma AG
6.9.1 S.L.A. Pharma AG Corporation Information
6.9.2 S.L.A. Pharma AG Description and Business Overview
6.9.3 S.L.A. Pharma AG Opioid Induced Constipation (OIC) Drugs Sales, Revenue and Gross Margin (2017-2022)
6.9.4 S.L.A. Pharma AG Opioid Induced Constipation (OIC) Drugs Product Portfolio
6.9.5 S.L.A. Pharma AG Recent Developments/Updates
6.10 Mundipharma International Limited
6.10.1 Mundipharma International Limited Corporation Information
6.10.2 Mundipharma International Limited Description and Business Overview
6.10.3 Mundipharma International Limited Opioid Induced Constipation (OIC) Drugs Sales, Revenue and Gross Margin (2017-2022)
6.10.4 Mundipharma International Limited Opioid Induced Constipation (OIC) Drugs Product Portfolio
6.10.5 Mundipharma International Limited Recent Developments/Updates
6.11 Ono Pharmaceutical Co., Ltd
6.11.1 Ono Pharmaceutical Co., Ltd Corporation Information
6.11.2 Ono Pharmaceutical Co., Ltd Opioid Induced Constipation (OIC) Drugs Description and Business Overview
6.11.3 Ono Pharmaceutical Co., Ltd Opioid Induced Constipation (OIC) Drugs Sales, Revenue and Gross Margin (2017-2022)
6.11.4 Ono Pharmaceutical Co., Ltd Opioid Induced Constipation (OIC) Drugs Product Portfolio
6.11.5 Ono Pharmaceutical Co., Ltd Recent Developments/Updates
6.12 Takeda Pharmaceutical Company Limited
6.12.1 Takeda Pharmaceutical Company Limited Corporation Information
6.12.2 Takeda Pharmaceutical Company Limited Opioid Induced Constipation (OIC) Drugs Description and Business Overview
6.12.3 Takeda Pharmaceutical Company Limited Opioid Induced Constipation (OIC) Drugs Sales, Revenue and Gross Margin (2017-2022)
6.12.4 Takeda Pharmaceutical Company Limited Opioid Induced Constipation (OIC) Drugs Product Portfolio
6.12.5 Takeda Pharmaceutical Company Limited Recent Developments/Updates
6.13 Theravance Biopharma Inc
6.13.1 Theravance Biopharma Inc Corporation Information
6.13.2 Theravance Biopharma Inc Opioid Induced Constipation (OIC) Drugs Description and Business Overview
6.13.3 Theravance Biopharma Inc Opioid Induced Constipation (OIC) Drugs Sales, Revenue and Gross Margin (2017-2022)
6.13.4 Theravance Biopharma Inc Opioid Induced Constipation (OIC) Drugs Product Portfolio
6.13.5 Theravance Biopharma Inc Recent Developments/Updates
6.14 Bausch Health
6.14.1 Bausch Health Corporation Information
6.14.2 Bausch Health Opioid Induced Constipation (OIC) Drugs Description and Business Overview
6.14.3 Bausch Health Opioid Induced Constipation (OIC) Drugs Sales, Revenue and Gross Margin (2017-2022)
6.14.4 Bausch Health Opioid Induced Constipation (OIC) Drugs Product Portfolio
6.14.5 Bausch Health Recent Developments/Updates
6.15 Cosmo Pharmaceuticals SA
6.15.1 Cosmo Pharmaceuticals SA Corporation Information
6.15.2 Cosmo Pharmaceuticals SA Opioid Induced Constipation (OIC) Drugs Description and Business Overview
6.15.3 Cosmo Pharmaceuticals SA Opioid Induced Constipation (OIC) Drugs Sales, Revenue and Gross Margin (2017-2022)
6.15.4 Cosmo Pharmaceuticals SA Opioid Induced Constipation (OIC) Drugs Product Portfolio
6.15.5 Cosmo Pharmaceuticals SA Recent Developments/Updates
6.16 Daewoong Pharmaceutical
6.16.1 Daewoong Pharmaceutical Corporation Information
6.16.2 Daewoong Pharmaceutical Opioid Induced Constipation (OIC) Drugs Description and Business Overview
6.16.3 Daewoong Pharmaceutical Opioid Induced Constipation (OIC) Drugs Sales, Revenue and Gross Margin (2017-2022)
6.16.4 Daewoong Pharmaceutical Opioid Induced Constipation (OIC) Drugs Product Portfolio
6.16.5 Daewoong Pharmaceutical Recent Developments/Updates
6.17 C.B. Fleet Company
6.17.1 C.B. Fleet Company Corporation Information
6.17.2 C.B. Fleet Company Opioid Induced Constipation (OIC) Drugs Description and Business Overview
6.17.3 C.B. Fleet Company Opioid Induced Constipation (OIC) Drugs Sales, Revenue and Gross Margin (2017-2022)
6.17.4 C.B. Fleet Company Opioid Induced Constipation (OIC) Drugs Product Portfolio
6.17.5 C.B. Fleet Company Recent Developments/Updates
6.18 Sucampo Pharmaceuticals
6.18.1 Sucampo Pharmaceuticals Corporation Information
6.18.2 Sucampo Pharmaceuticals Opioid Induced Constipation (OIC) Drugs Description and Business Overview
6.18.3 Sucampo Pharmaceuticals Opioid Induced Constipation (OIC) Drugs Sales, Revenue and Gross Margin (2017-2022)
6.18.4 Sucampo Pharmaceuticals Opioid Induced Constipation (OIC) Drugs Product Portfolio
6.18.5 Sucampo Pharmaceuticals Recent Developments/Updates
7 Opioid Induced Constipation (OIC) Drugs Manufacturing Cost Analysis
7.1 Opioid Induced Constipation (OIC) Drugs Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Opioid Induced Constipation (OIC) Drugs
7.4 Opioid Induced Constipation (OIC) Drugs Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Opioid Induced Constipation (OIC) Drugs Distributors List
8.3 Opioid Induced Constipation (OIC) Drugs Customers
9 Opioid Induced Constipation (OIC) Drugs Market Dynamics
9.1 Opioid Induced Constipation (OIC) Drugs Industry Trends
9.2 Opioid Induced Constipation (OIC) Drugs Market Drivers
9.3 Opioid Induced Constipation (OIC) Drugs Market Challenges
9.4 Opioid Induced Constipation (OIC) Drugs Market Restraints
10 Global Market Forecast
10.1 Opioid Induced Constipation (OIC) Drugs Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Opioid Induced Constipation (OIC) Drugs by Type (2023-2028)
10.1.2 Global Forecasted Revenue of Opioid Induced Constipation (OIC) Drugs by Type (2023-2028)
10.2 Opioid Induced Constipation (OIC) Drugs Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Opioid Induced Constipation (OIC) Drugs by Application (2023-2028)
10.2.2 Global Forecasted Revenue of Opioid Induced Constipation (OIC) Drugs by Application (2023-2028)
10.3 Opioid Induced Constipation (OIC) Drugs Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Opioid Induced Constipation (OIC) Drugs by Region (2023-2028)
10.3.2 Global Forecasted Revenue of Opioid Induced Constipation (OIC) Drugs by Region (2023-2028)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
Table 1. Global Opioid Induced Constipation (OIC) Drugs Sales Growth Rate Comparison by Type (2022-2028) & (K Dose) & (US$ Million)
Table 2. Global Opioid Induced Constipation (OIC) Drugs Sales Growth Rate Comparison by Application (2022-2028) & (K Dose) & (US$ Million)
Table 3. Global Opioid Induced Constipation (OIC) Drugs Market Size by Region (US$ Million) (2017 VS 2021 VS 2028)
Table 4. Global Opioid Induced Constipation (OIC) Drugs Market Competitive Situation by Manufacturers in 2021
Table 5. Global Opioid Induced Constipation (OIC) Drugs Sales (K Dose) of Key Manufacturers (2017-2022)
Table 6. Global Opioid Induced Constipation (OIC) Drugs Sales Market Share by Manufacturers (2017-2022)
Table 7. Global Opioid Induced Constipation (OIC) Drugs Revenue (US$ Million) by Manufacturers (2017-2022)
Table 8. Global Opioid Induced Constipation (OIC) Drugs Revenue Share by Manufacturers (2017-2022)
Table 9. Global Market Opioid Induced Constipation (OIC) Drugs Average Price (USD/Dose) of Key Manufacturers (2017-2022)
Table 10. Manufacturers Opioid Induced Constipation (OIC) Drugs Manufacturing Sites and Area Served
Table 11. Manufacturers Opioid Induced Constipation (OIC) Drugs Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Opioid Induced Constipation (OIC) Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Opioid Induced Constipation (OIC) Drugs as of 2021)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Opioid Induced Constipation (OIC) Drugs Sales by Region (2017-2022) & (K Dose)
Table 16. Global Opioid Induced Constipation (OIC) Drugs Sales Market Share by Region (2017-2022)
Table 17. Global Opioid Induced Constipation (OIC) Drugs Revenue by Region (2017-2022) & (US$ Million)
Table 18. Global Opioid Induced Constipation (OIC) Drugs Revenue Market Share by Region (2017-2022)
Table 19. North America Opioid Induced Constipation (OIC) Drugs Sales by Country (2017-2022) & (K Dose)
Table 20. North America Opioid Induced Constipation (OIC) Drugs Sales Market Share by Country (2017-2022)
Table 21. North America Opioid Induced Constipation (OIC) Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 22. North America Opioid Induced Constipation (OIC) Drugs Revenue Market Share by Country (2017-2022)
Table 23. Europe Opioid Induced Constipation (OIC) Drugs Sales by Country (2017-2022) & (K Dose)
Table 24. Europe Opioid Induced Constipation (OIC) Drugs Sales Market Share by Country (2017-2022)
Table 25. Europe Opioid Induced Constipation (OIC) Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 26. Europe Opioid Induced Constipation (OIC) Drugs Revenue Market Share by Country (2017-2022)
Table 27. Asia Pacific Opioid Induced Constipation (OIC) Drugs Sales by Region (2017-2022) & (K Dose)
Table 28. Asia Pacific Opioid Induced Constipation (OIC) Drugs Sales Market Share by Region (2017-2022)
Table 29. Asia Pacific Opioid Induced Constipation (OIC) Drugs Revenue by Region (2017-2022) & (US$ Million)
Table 30. Asia Pacific Opioid Induced Constipation (OIC) Drugs Revenue Market Share by Region (2017-2022)
Table 31. Latin America Opioid Induced Constipation (OIC) Drugs Sales by Country (2017-2022) & (K Dose)
Table 32. Latin America Opioid Induced Constipation (OIC) Drugs Sales Market Share by Country (2017-2022)
Table 33. Latin America Opioid Induced Constipation (OIC) Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 34. Latin America Opioid Induced Constipation (OIC) Drugs Revenue Market Share by Country (2017-2022)
Table 35. Middle East and Africa Opioid Induced Constipation (OIC) Drugs Sales by Country (2017-2022) & (K Dose)
Table 36. Middle East and Africa Opioid Induced Constipation (OIC) Drugs Sales Market Share by Country (2017-2022)
Table 37. Middle East and Africa Opioid Induced Constipation (OIC) Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 38. Middle East and Africa Opioid Induced Constipation (OIC) Drugs Revenue Market Share by Country (2017-2022)
Table 39. Global Opioid Induced Constipation (OIC) Drugs Sales by Type (2017-2022) & (K Dose)
Table 40. Global Opioid Induced Constipation (OIC) Drugs Sales Market Share by Type (2017-2022)
Table 41. Global Opioid Induced Constipation (OIC) Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 42. Global Opioid Induced Constipation (OIC) Drugs Revenue Share by Type (2017-2022)
Table 43. Global Opioid Induced Constipation (OIC) Drugs Price by Type (2017-2022) & (USD/Dose)
Table 44. Global Opioid Induced Constipation (OIC) Drugs Sales (K Dose) by Application (2017-2022)
Table 45. Global Opioid Induced Constipation (OIC) Drugs Sales Market Share by Application (2017-2022)
Table 46. Global Opioid Induced Constipation (OIC) Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 47. Global Opioid Induced Constipation (OIC) Drugs Revenue Share by Application (2017-2022)
Table 48. Global Opioid Induced Constipation (OIC) Drugs Price by Application (2017-2022) & (USD/Dose)
Table 49. Ironwood Pharmaceuticals Inc Corporation Information
Table 50. Ironwood Pharmaceuticals Inc Description and Business Overview
Table 51. Ironwood Pharmaceuticals Inc Opioid Induced Constipation (OIC) Drugs Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 52. Ironwood Pharmaceuticals Inc Opioid Induced Constipation (OIC) Drugs Product
Table 53. Ironwood Pharmaceuticals Inc Recent Developments/Updates
Table 54. Daiichi Sankyo Co Ltd Corporation Information
Table 55. Daiichi Sankyo Co Ltd Description and Business Overview
Table 56. Daiichi Sankyo Co Ltd Opioid Induced Constipation (OIC) Drugs Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 57. Daiichi Sankyo Co Ltd Opioid Induced Constipation (OIC) Drugs Product
Table 58. Daiichi Sankyo Co Ltd Recent Developments/Updates
Table 59. Pfizer Corporation Information
Table 60. Pfizer Description and Business Overview
Table 61. Pfizer Opioid Induced Constipation (OIC) Drugs Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 62. Pfizer Opioid Induced Constipation (OIC) Drugs Product
Table 63. Pfizer Recent Developments/Updates
Table 64. Progenics Pharmaceuticals Inc Corporation Information
Table 65. Progenics Pharmaceuticals Inc Description and Business Overview
Table 66. Progenics Pharmaceuticals Inc Opioid Induced Constipation (OIC) Drugs Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 67. Progenics Pharmaceuticals Inc Opioid Induced Constipation (OIC) Drugs Product
Table 68. Progenics Pharmaceuticals Inc Recent Developments/Updates
Table 69. Shionogi & Co., Ltd Corporation Information
Table 70. Shionogi & Co., Ltd Description and Business Overview
Table 71. Shionogi & Co., Ltd Opioid Induced Constipation (OIC) Drugs Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 72. Shionogi & Co., Ltd Opioid Induced Constipation (OIC) Drugs Product
Table 73. Shionogi & Co., Ltd Recent Developments/Updates
Table 74. Allergan Plc Corporation Information
Table 75. Allergan Plc Description and Business Overview
Table 76. Allergan Plc Opioid Induced Constipation (OIC) Drugs Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 77. Allergan Plc Opioid Induced Constipation (OIC) Drugs Product
Table 78. Allergan Plc Recent Developments/Updates
Table 79. Nektar Therapeutics Corporation Information
Table 80. Nektar Therapeutics Description and Business Overview
Table 81. Nektar Therapeutics Opioid Induced Constipation (OIC) Drugs Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 82. Nektar Therapeutics Opioid Induced Constipation (OIC) Drugs Product
Table 83. Nektar Therapeutics Recent Developments/Updates
Table 84. Purdue Pharma Corporation Information
Table 85. Purdue Pharma Description and Business Overview
Table 86. Purdue Pharma Opioid Induced Constipation (OIC) Drugs Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 87. Purdue Pharma Opioid Induced Constipation (OIC) Drugs Product
Table 88. Purdue Pharma Recent Developments/Updates
Table 89. S.L.A. Pharma AG Corporation Information
Table 90. S.L.A. Pharma AG Description and Business Overview
Table 91. S.L.A. Pharma AG Opioid Induced Constipation (OIC) Drugs Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 92. S.L.A. Pharma AG Opioid Induced Constipation (OIC) Drugs Product
Table 93. S.L.A. Pharma AG Recent Developments/Updates
Table 94. Mundipharma International Limited Corporation Information
Table 95. Mundipharma International Limited Description and Business Overview
Table 96. Mundipharma International Limited Opioid Induced Constipation (OIC) Drugs Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 97. Mundipharma International Limited Opioid Induced Constipation (OIC) Drugs Product
Table 98. Mundipharma International Limited Recent Developments/Updates
Table 99. Ono Pharmaceutical Co., Ltd Corporation Information
Table 100. Ono Pharmaceutical Co., Ltd Description and Business Overview
Table 101. Ono Pharmaceutical Co., Ltd Opioid Induced Constipation (OIC) Drugs Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 102. Ono Pharmaceutical Co., Ltd Opioid Induced Constipation (OIC) Drugs Product
Table 103. Ono Pharmaceutical Co., Ltd Recent Developments/Updates
Table 104. Takeda Pharmaceutical Company Limited Corporation Information
Table 105. Takeda Pharmaceutical Company Limited Description and Business Overview
Table 106. Takeda Pharmaceutical Company Limited Opioid Induced Constipation (OIC) Drugs Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 107. Takeda Pharmaceutical Company Limited Opioid Induced Constipation (OIC) Drugs Product
Table 108. Takeda Pharmaceutical Company Limited Recent Developments/Updates
Table 109. Theravance Biopharma Inc Corporation Information
Table 110. Theravance Biopharma Inc Description and Business Overview
Table 111. Theravance Biopharma Inc Opioid Induced Constipation (OIC) Drugs Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 112. Theravance Biopharma Inc Opioid Induced Constipation (OIC) Drugs Product
Table 113. Theravance Biopharma Inc Recent Developments/Updates
Table 114. Bausch Health Corporation Information
Table 115. Bausch Health Description and Business Overview
Table 116. Bausch Health Opioid Induced Constipation (OIC) Drugs Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 117. Bausch Health Opioid Induced Constipation (OIC) Drugs Product
Table 118. Bausch Health Recent Developments/Updates
Table 119. Cosmo Pharmaceuticals SA Corporation Information
Table 120. Cosmo Pharmaceuticals SA Description and Business Overview
Table 121. Cosmo Pharmaceuticals SA Opioid Induced Constipation (OIC) Drugs Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 122. Cosmo Pharmaceuticals SA Opioid Induced Constipation (OIC) Drugs Product
Table 123. Cosmo Pharmaceuticals SA Recent Developments/Updates
Table 124. Daewoong Pharmaceutical Corporation Information
Table 125. Daewoong Pharmaceutical Description and Business Overview
Table 126. Daewoong Pharmaceutical Opioid Induced Constipation (OIC) Drugs Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 127. Daewoong Pharmaceutical Opioid Induced Constipation (OIC) Drugs Product
Table 128. Daewoong Pharmaceutical Recent Developments/Updates
Table 129. C.B. Fleet Company Corporation Information
Table 130. C.B. Fleet Company Description and Business Overview
Table 131. C.B. Fleet Company Opioid Induced Constipation (OIC) Drugs Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 132. C.B. Fleet Company Opioid Induced Constipation (OIC) Drugs Product
Table 133. C.B. Fleet Company Recent Developments/Updates
Table 134. Sucampo Pharmaceuticals Corporation Information
Table 135. Sucampo Pharmaceuticals Description and Business Overview
Table 136. Sucampo Pharmaceuticals Opioid Induced Constipation (OIC) Drugs Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 137. Sucampo Pharmaceuticals Opioid Induced Constipation (OIC) Drugs Product
Table 138. Sucampo Pharmaceuticals Recent Developments/Updates
Table 139. Production Base and Market Concentration Rate of Raw Material
Table 140. Key Suppliers of Raw Materials
Table 141. Opioid Induced Constipation (OIC) Drugs Distributors List
Table 142. Opioid Induced Constipation (OIC) Drugs Customers List
Table 143. Opioid Induced Constipation (OIC) Drugs Market Trends
Table 144. Opioid Induced Constipation (OIC) Drugs Market Drivers
Table 145. Opioid Induced Constipation (OIC) Drugs Market Challenges
Table 146. Opioid Induced Constipation (OIC) Drugs Market Restraints
Table 147. Global Opioid Induced Constipation (OIC) Drugs Sales Forecast by Type (2023-2028) & (K Dose)
Table 148. Global Opioid Induced Constipation (OIC) Drugs Sales Market Share Forecast by Type (2023-2028)
Table 149. Global Opioid Induced Constipation (OIC) Drugs Revenue Forecast by Type (2023-2028) & (US$ Million)
Table 150. Global Opioid Induced Constipation (OIC) Drugs Revenue Market Share Forecast by Type (2023-2028)
Table 151. Global Opioid Induced Constipation (OIC) Drugs Sales Forecast by Application (2023-2028) & (K Dose)
Table 152. Global Opioid Induced Constipation (OIC) Drugs Sales Market Share Forecast by Application (2023-2028)
Table 153. Global Opioid Induced Constipation (OIC) Drugs Revenue Forecast by Application (2023-2028) & (US$ Million)
Table 154. Global Opioid Induced Constipation (OIC) Drugs Revenue Market Share Forecast by Application (2023-2028)
Table 155. Global Opioid Induced Constipation (OIC) Drugs Sales Forecast by Region (2023-2028) & (K Dose)
Table 156. Global Opioid Induced Constipation (OIC) Drugs Sales Market Share Forecast by Region (2023-2028)
Table 157. Global Opioid Induced Constipation (OIC) Drugs Revenue Forecast by Region (2023-2028) & (US$ Million)
Table 158. Global Opioid Induced Constipation (OIC) Drugs Revenue Market Share Forecast by Region (2023-2028)
Table 159. Research Programs/Design for This Report
Table 160. Key Data Information from Secondary Sources
Table 161. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Opioid Induced Constipation (OIC) Drugs
Figure 2. Global Opioid Induced Constipation (OIC) Drugs Market Share by Type in 2021 & 2028
Figure 3. Lubiprostone Product Picture
Figure 4. Methyl Naltrexone Bromide Product Picture
Figure 5. Naldemedine Product Picture
Figure 6. Alvimopan Product Picture
Figure 7. Others Product Picture
Figure 8. Global Opioid Induced Constipation (OIC) Drugs Market Share by Application in 2021 & 2028
Figure 9. Hospital Pharmacies
Figure 10. Retail Pharmacies
Figure 11. Online Pharmacies
Figure 12. Global Opioid Induced Constipation (OIC) Drugs Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 13. Global Opioid Induced Constipation (OIC) Drugs Market Size (2017-2028) & (US$ Million)
Figure 14. Global Opioid Induced Constipation (OIC) Drugs Sales (2017-2028) & (K Dose)
Figure 15. Opioid Induced Constipation (OIC) Drugs Sales Share by Manufacturers in 2021
Figure 16. Global Opioid Induced Constipation (OIC) Drugs Revenue Share by Manufacturers in 2021
Figure 17. The Global 5 and 10 Largest Opioid Induced Constipation (OIC) Drugs Players: Market Share by Revenue in 2021
Figure 18. Opioid Induced Constipation (OIC) Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
Figure 19. Global Opioid Induced Constipation (OIC) Drugs Sales Market Share by Region (2017-2022)
Figure 20. Global Opioid Induced Constipation (OIC) Drugs Sales Market Share by Region in 2021
Figure 21. Global Opioid Induced Constipation (OIC) Drugs Revenue Market Share by Region (2017-2022)
Figure 22. Global Opioid Induced Constipation (OIC) Drugs Revenue Market Share by Region in 2021
Figure 23. U.S. Opioid Induced Constipation (OIC) Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 24. Canada Opioid Induced Constipation (OIC) Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 25. Germany Opioid Induced Constipation (OIC) Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 26. France Opioid Induced Constipation (OIC) Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 27. U.K. Opioid Induced Constipation (OIC) Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 28. Italy Opioid Induced Constipation (OIC) Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 29. Russia Opioid Induced Constipation (OIC) Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 30. China Opioid Induced Constipation (OIC) Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 31. Japan Opioid Induced Constipation (OIC) Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 32. South Korea Opioid Induced Constipation (OIC) Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 33. India Opioid Induced Constipation (OIC) Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 34. Australia Opioid Induced Constipation (OIC) Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 35. Taiwan Opioid Induced Constipation (OIC) Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 36. Indonesia Opioid Induced Constipation (OIC) Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 37. Thailand Opioid Induced Constipation (OIC) Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 38. Malaysia Opioid Induced Constipation (OIC) Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 39. Philippines Opioid Induced Constipation (OIC) Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 40. Vietnam Opioid Induced Constipation (OIC) Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 41. Mexico Opioid Induced Constipation (OIC) Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 42. Brazil Opioid Induced Constipation (OIC) Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 43. Argentina Opioid Induced Constipation (OIC) Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 44. Turkey Opioid Induced Constipation (OIC) Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 45. Saudi Arabia Opioid Induced Constipation (OIC) Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 46. U.A.E Opioid Induced Constipation (OIC) Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 47. Sales Market Share of Opioid Induced Constipation (OIC) Drugs by Type (2017-2022)
Figure 48. Manufacturing Cost Structure of Opioid Induced Constipation (OIC) Drugs
Figure 49. Manufacturing Process Analysis of Opioid Induced Constipation (OIC) Drugs
Figure 50. Opioid Induced Constipation (OIC) Drugs Industrial Chain Analysis
Figure 51. Channels of Distribution
Figure 52. Distributors Profiles
Figure 53. Bottom-up and Top-down Approaches for This Report
Figure 54. Data Triangulation
Figure 55. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Ironwood Pharmaceuticals Inc Daiichi Sankyo Co Ltd Pfizer Progenics Pharmaceuticals Inc Shionogi & Co., Ltd Allergan Plc Nektar Therapeutics Purdue Pharma S.L.A. Pharma AG Mundipharma International Limited Ono Pharmaceutical Co., Ltd Takeda Pharmaceutical Company Limited Theravance Biopharma Inc Bausch Health Cosmo Pharmaceuticals SA Daewoong Pharmaceutical C.B. Fleet Company Sucampo Pharmaceuticals